medical guideline
首页
中医/中西医结合指南
肿瘤学指南
泌尿外科指南
关于我们
郑重声明
联系我们
首页
肿瘤学指南
检索结果
人体系统
运动
骨肿瘤
软组织肿瘤
骨与软组织肿瘤
硬纤维瘤
骶尾部畸胎瘤
神经
中枢神经系统肿瘤
胶质细胞瘤
前庭神经鞘瘤
神经内分泌肿瘤
神经细胞瘤
嗜铬细胞瘤和副神经节瘤
副神经节瘤
星形胶质细胞瘤和少突胶质细胞瘤
弥漫性胶质瘤
神经纤维瘤
内分泌
神经内分泌肿瘤
甲状腺肿瘤
垂体肿瘤
肾上腺肿瘤
胸腺肿瘤
甲状旁腺肿瘤
循环
心脏肿瘤
淋巴瘤
骨髓瘤
白血病
血液肿瘤
血管瘤
呼吸
肺癌
鼻咽癌
喉部肿瘤
下咽癌
鼻腔和副鼻窦癌
呼吸道肿瘤
鼻颅咽管瘤
淋巴管肌瘤
消化
胰腺肿瘤
口腔癌
肛门癌
口咽癌
胆囊癌
胆管肿瘤
直肠癌
结肠癌
胃癌
小肠癌
肝癌
大肠肿瘤
唾液腺癌
阑尾肿瘤
食管肿瘤
肝肿瘤
结直肠肿瘤
肝胆癌
食管胃肿瘤
胃肠道肿瘤
消化道肿瘤
壶腹肿瘤
泌尿
膀胱肿瘤
肾癌
尿路上皮癌
泌尿生殖肿瘤
脐尿管癌
肾血管平滑肌脂肪瘤
生殖
女性
子宫肿瘤
卵巢肿瘤
乳腺肿瘤
阴道肿瘤
外阴癌
妊娠滋养细胞肿瘤
妇科肿瘤
男性
前列腺肿瘤
睾丸肿瘤
阴茎癌
男性乳腺肿瘤
泌尿生殖肿瘤
输卵管癌
性索间质瘤
其他
症状管理
皮肤肿瘤
腹膜肿瘤
实体瘤
老年肿瘤
儿童/青少年肿瘤
头颈部肿瘤
治疗方案
诊断/检测/评估方法
预防和筛查
COVID-19大流行癌症患者相关指导建议
黑色素瘤
康复营养
生育能力
体力活动
心理健康
胸部肿瘤
长期监测
Cowden综合征
转诊
遗传性癌症综合征
癌症患者其他类问题管理
寡转移性疾病
基因测序
易感基因变异的分类
外科肿瘤
罕见癌症
不明原因癌症
纤维瘤
腹部肿瘤
人类微生物组与癌变
检索结果
按关键字
按标题
按关键词
按摘要
按作者
按期刊
按发表年份
共搜索到
790条
与
ENT
有关的结果
Distress Management
2021年 发布于
National Comprehensive Cancer Network
卷 第期
所属人体系统：
其他
|
心理健康
National Comprehensive Cancer Network
Cancer
distress
evaluation
treatment
care
指南简介
原文链接
Distress During Cancer Care(Guideline for Patients)
2021年 发布于
National Comprehensive Cancer Network
卷 第期
所属人体系统：
其他
|
心理健康
National Comprehensive Cancer Network
Patients
Distress
Cancer
management
指南简介
原文链接
The 2020 Japan Society of Gynecologic Oncology Guidelines for the Treatment of Ovarian Cancer, Fallopian Tube Cancer, and Primary Peritoneal Cancer
2021年 发布于
Journal of Gynecologic Oncology
32卷 第2期
所属人体系统：
其他
|
腹膜肿瘤
Japan Society of Gynecologic Oncology
The Fifth Edition of the Japan Society of Gynecologic Oncology Guidelines for the Treatment of Ovarian Cancer
Fallopian Tube Cancer
and Primary Peritoneal Cancer Was Published in 2020. the Guidelines Contain 6 Chapters-namely
(1) Overview of the Guidelines
(2) Epithelial Ovarian Cancer
Fallopian Tube Cancer
and Primary Peritoneal Cancer
(3) Recurrent Epithelial Ovarian Cancer
Fallopian Tube Cancer
and Primary Peritoneal Cancer
(4) Borderline Epithelial Tumors of the Ovary
(5) Malignant Germ Cell Tumors of the Ovary
and (6) Malignant Sex Cord-stromal Tumors. Furthermore
the Guidelines Comprise 5 Algorithms-namely
(1) Initial Treatment for Ovarian Cancer
Fallopian Tube Cancer
and Primary Peritoneal Cancer
(2) Treatment for Recurrent Ovarian Cancer
Fallopian Tube Cancer
and Primary Peritoneal Cancer
(3) Initial Treatment for Borderline Epithelial Ovarian Tumor
(4) Treatment for Malignant Germ Cell Tumor
and (5) Treatment for Sex Cord-stromal Tumor. Major Changes in the New Edition Include the Following: (1) Revision of the Title to "guidelines for the Treatment of Ovarian Cancer
Fallopian Tube Cancer
and Primary Peritoneal Cancer"
(2) Involvement of Patients and General (male/female) Participants in Addition to Physicians
Pharmacists
and Nurses
(3) Clinical Questions (CQs) in the PICO Format
(4) Change in the Expression of Grades of Recommendation and Level of Evidence in Accordance with the GRADE System
(5) Introduction of the Idea of a Body of Evidence
(6) Categorization of References According to Research Design
(7) Performance of Systematic Reviews and Meta-analysis for Three CQs
and (8) Voting for Each CQ/recommendation and Description of the Consensus.
指南简介
原文链接
An Ontario Health (Cancer Care Ontario) Clinical Practice Guideline: Consolidation Or Maintenance Systemic Therapy for Newly Diagnosed Stage Ii, Iii, Or Iv Epithelial Ovary, Fallopian Tube, Or Primary Peritoneal Carcinoma
2021年 发布于
Current Oncology
28卷 第2期
所属人体系统：
其他
|
腹膜肿瘤
Ontario Health (Cancer Care Ontario)
Objective: to Provide Recommendations on Systemic Therapy Options in Consolidation Or Maintenance Therapy for Women with Newly Diagnosed Stage II
III
Or IV Epithelial Ovary
Fallopian Tube
Or Primary Peritoneal Carcinoma Including All Histological Types.
Methods: Consistent with the Program in Evidence-based Program's Standardized Approach
MEDLINE
EMBASE
PubMed
Cochrane Library
and PROSPERO (the International Prospective Register of Systematic Reviews) Databases
and Four Relevant Conferences Were Systematically Searched. the Working Group Drafted Recommendations and Revised Them Based on the Comments from Internal and External Reviewers.
Results: We Have One Recommendation for Consolidation Therapy and Eight Recommendations for Maintenance Therapy. Overall
Consolidation Therapy with Chemotherapy Should Not Be Recommended in the Target Population. for Maintenance Therapy
We Recommended Olaparib (Recommendation)
Niraparib (Weak Recommendation)
Veliparib (Weak Recommendation)
and Bevacizumab (Weak Recommendation) for Certain Patients with Newly Diagnosed Stage III-IV Epithelial Ovarian
Fallopian Tube
Or Primary Peritoneal Carcinoma
Respectively. We Do Not Recommend Some Agents as Maintenance Therapy in Four Recommendations. We Are Unable to Specify the Patient Population by Histological Types for Different Maintenance Therapy Recommendations. When New Evidence That Can Impact the Recommendations Is Available
the Recommendations Will Be Updated as Soon as Possible.
指南简介
原文链接
Malignant Pleural Mesothelioma(Guideline for Patients)
2021年 发布于
National Comprehensive Cancer Network
卷 第期
所属人体系统：
其他
|
胸部肿瘤
National Comprehensive Cancer Network
Patients
Malignant
Pleural Mesothelioma
testing
treatment
指南简介
原文链接
Survivorship Care for Cancer-Related Late and Long-Term Effects(Guideline for Patients)
2021年 发布于
National Comprehensive Cancer Network
卷 第期
所属人体系统：
其他
|
长期监测
National Comprehensive Cancer Network
Patient
Survivorship
cancer
long-term
symptom
指南简介
原文链接
Survivorship Care for Healthy Living(Guideline for Patients)
2021年 发布于
National Comprehensive Cancer Network
卷 第期
所属人体系统：
其他
|
长期监测
National Comprehensive Cancer Network
Patient
Survivorship
care
指南简介
原文链接
American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Guideline for Management of Hereditary Breast Cancer
2021年 发布于
JAMA Surgery
28卷 第1期
所属人体系统：
生殖
|
乳腺肿瘤
American Society of Clinical Oncology
American Society for Radiation Oncology
and Society of Surgical Oncology
Hereditary Breast Cancer
Management
Guideline
指南简介
原文链接
Clinical Practice Guidelines for Sentinel Lymph Node Biopsy in Patients with Early-stage Breast Cancer: Chinese Society of Breast Surgery (CSBrS) Practice Guidelines 2021
2021年 发布于
Chin Med J (Engl)
134卷 第8期
所属人体系统：
生殖
|
乳腺肿瘤
Chinese Society of Breast Surgery
Early-stage Breast Cancer
Sentinel Lymph Node Biopsy
Guideline
指南简介
原文链接
Procedur Guideline for Lymphoscintigraphy and Sentinel Lymph Node in Breast Cancer
2021年 发布于
Nuclear Medicine Seminars
6卷 第3期
所属人体系统：
生殖
|
乳腺肿瘤
Turkish Society of Nuclear Medine Oncology Task Group
Reast Cancer
Gamma Camera
Gamma Probe
Lymphoscintigraphy
Sentinel Lymph Node
指南简介
原文链接
Individualizing Surveillance Mammography for Older Patients after Treatment for Early-Stage Breast Cancer: Multidisciplinary Expert Panel and International Society of Geriatric Oncology Consensus Statement
2021年 发布于
JAMA Oncology
7卷 第4期
所属人体系统：
生殖
|
乳腺肿瘤
International Society of Geriatric Oncology
Early-stage Breast Cancer
Older Patients
Treatment
Individualizing Surveillance Mammography
Consensus
指南简介
原文链接
Breast Conservation and Axillary Management after Primary Systemic Therapy in Patients with Early-stage Breast Cancer: the Lucerne Toolbox
2021年 发布于
Lancet Oncol
22卷 第1期
所属人体系统：
生殖
|
乳腺肿瘤
European Society of Surgical Oncology
European Society for Radiotherapy and Oncology；European Society of Breast Imaging；European Society of Breast Cancer Specialists
European School of Oncology；European Society for Medical Oncology； EUROPA DONNA–The European Breast Cancer Coalition
Austrian Breast and Colorectal Cancer Study Group
International Breast Cancer Study Group
German Breast Group
Swiss Working Group for Clinical Cancer Research
Swiss Society of Senology
and Hirslanden Network of Breast Cancer Centers
Early-stage Breast Cancer
Systemic Therapy
Breast Conservation
Axillary Management
Guideline
指南简介
原文链接
2020 Consensus Guideline for Optimal Approach to the Diagnosis and Treatment of HER2-positive Breast Cancer in Bosnia and Herzegovina
2021年 发布于
Bosnian journal of basic medical sciences
21卷 第2期
所属人体系统：
生殖
|
乳腺肿瘤
HERe2Cure Project Including Members of Multidisciplinary Tumor Boards from Healthcare Institutions in Bosnia and Herzegovina
HER2-positive
Breast Cancer
Diagnosis
Treatment
Guideline
指南简介
原文链接
Interdisciplinary S2k Guidelines on the Diagnosis and Treatment of Vaginal Carcinoma and Its Precursors-recommendations on Surgical Pathology for Histopathological Workup, Diagnostics, and Reporting
2021年 发布于
Pathologe
42卷 第1期
所属人体系统：
生殖
|
阴道肿瘤
无
Cancer
Diagnostic
Guidelines
Histopathology
Prognosis
Staging
Treatment
VaIN
Vagina
WHO
Workup
指南简介
原文链接
The 2020 Japan Society of Gynecologic Oncology Guidelines for the Treatment of Ovarian Cancer, Fallopian Tube Cancer, and Primary Peritoneal Cancer
2021年 发布于
Journal of Gynecologic Oncology
32卷 第2期
所属人体系统：
生殖
|
输卵管癌
Japan Society of Gynecologic Oncology
The Fifth Edition of the Japan Society of Gynecologic Oncology Guidelines for the Treatment of Ovarian Cancer
Fallopian Tube Cancer
and Primary Peritoneal Cancer Was Published in 2020. the Guidelines Contain 6 Chapters-namely
(1) Overview of the Guidelines
(2) Epithelial Ovarian Cancer
Fallopian Tube Cancer
and Primary Peritoneal Cancer
(3) Recurrent Epithelial Ovarian Cancer
Fallopian Tube Cancer
and Primary Peritoneal Cancer
(4) Borderline Epithelial Tumors of the Ovary
(5) Malignant Germ Cell Tumors of the Ovary
and (6) Malignant Sex Cord-stromal Tumors. Furthermore
the Guidelines Comprise 5 Algorithms-namely
(1) Initial Treatment for Ovarian Cancer
Fallopian Tube Cancer
and Primary Peritoneal Cancer
(2) Treatment for Recurrent Ovarian Cancer
Fallopian Tube Cancer
and Primary Peritoneal Cancer
(3) Initial Treatment for Borderline Epithelial Ovarian Tumor
(4) Treatment for Malignant Germ Cell Tumor
and (5) Treatment for Sex Cord-stromal Tumor. Major Changes in the New Edition Include the Following: (1) Revision of the Title to "guidelines for the Treatment of Ovarian Cancer
Fallopian Tube Cancer
and Primary Peritoneal Cancer"
(2) Involvement of Patients and General (male/female) Participants in Addition to Physicians
Pharmacists
and Nurses
(3) Clinical Questions (CQs) in the PICO Format
(4) Change in the Expression of Grades of Recommendation and Level of Evidence in Accordance with the GRADE System
(5) Introduction of the Idea of a Body of Evidence
(6) Categorization of References According to Research Design
(7) Performance of Systematic Reviews and Meta-analysis for Three CQs
and (8) Voting for Each CQ/recommendation and Description of the Consensus.
指南简介
原文链接
An Ontario Health (Cancer Care Ontario) Clinical Practice Guideline: Consolidation Or Maintenance Systemic Therapy for Newly Diagnosed Stage Ii, Iii, Or Iv Epithelial Ovary, Fallopian Tube, Or Primary Peritoneal Carcinoma
2021年 发布于
Current Oncology
28卷 第2期
所属人体系统：
生殖
|
输卵管癌
Ontario Health (Cancer Care Ontario)
Objective: to Provide Recommendations on Systemic Therapy Options in Consolidation Or Maintenance Therapy for Women with Newly Diagnosed Stage II
III
Or IV Epithelial Ovary
Fallopian Tube
Or Primary Peritoneal Carcinoma Including All Histological Types.
Methods: Consistent with the Program in Evidence-based Program's Standardized Approach
MEDLINE
EMBASE
PubMed
Cochrane Library
and PROSPERO (the International Prospective Register of Systematic Reviews) Databases
and Four Relevant Conferences Were Systematically Searched. the Working Group Drafted Recommendations and Revised Them Based on the Comments from Internal and External Reviewers.
Results: We Have One Recommendation for Consolidation Therapy and Eight Recommendations for Maintenance Therapy. Overall
Consolidation Therapy with Chemotherapy Should Not Be Recommended in the Target Population. for Maintenance Therapy
We Recommended Olaparib (Recommendation)
Niraparib (Weak Recommendation)
Veliparib (Weak Recommendation)
and Bevacizumab (Weak Recommendation) for Certain Patients with Newly Diagnosed Stage III-IV Epithelial Ovarian
Fallopian Tube
Or Primary Peritoneal Carcinoma
Respectively. We Do Not Recommend Some Agents as Maintenance Therapy in Four Recommendations. We Are Unable to Specify the Patient Population by Histological Types for Different Maintenance Therapy Recommendations. When New Evidence That Can Impact the Recommendations Is Available
the Recommendations Will Be Updated as Soon as Possible.
指南简介
原文链接
Initial Management of Noncastrate Advanced, Recurrent, Or Metastatic Prostate Cancer: ASCO Guideline Update
2021年 发布于
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
39卷 第11期
所属人体系统：
生殖
|
前列腺肿瘤
American Society of Clinical Oncology
Noncastrate Advanced
Recurrent
Metastatic Prostate Cancer
Management
Guideline
指南简介
原文链接
Consensus on the Treatment and Follow-Up for the Nonmetastatic Castration-Resistant Prostate Cancer: a Report from the First Prostate Cancer Consensus Conference for Developing Countries
2021年 发布于
JCO Glob Oncol
7卷 第期
所属人体系统：
生殖
|
前列腺肿瘤
Prostate Cancer Consensus Conference for Developing Countries
Nonmetastatic
Castration-resistant
Prostate Cancer
Treatment
Follow-up
Consensus
指南简介
原文链接
EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer—2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent
2021年 发布于
European Urology
79卷 第2期
所属人体系统：
生殖
|
前列腺肿瘤
European Association of Urology
European Association of Nuclear Medicine
European Society for Radiotherapy and Oncology
European Society of Urogenital Radiology
International Society of Geriatric Oncology
Active Surveillance
Androgen Deprivation
Diagnosis
EAU-EANM-ESTRO-ESUR-SIOG Guidelines
Localised
Prostate Cancer
Quality of Life
Radiation Therapy
Radical Prostatectomy
Screening
Staging
Treatment
指南简介
原文链接
Consensus on Treatment and Follow-Up for Biochemical Recurrence in Castration-Sensitive Prostate Cancer: a Report from the First Global Prostate Cancer Consensus Conference for Developing Countries
2021年 发布于
JCO Glob Oncol
7卷 第期
所属人体系统：
生殖
|
前列腺肿瘤
First Global Prostate Cancer Consensus Conference for Developing Countries
Prostate Cancer
Treatment
Follow-up
Consensus
指南简介
原文链接
首页
1
2
3
4
5
6
7
8
9
10
...
39
40
下一页
尾页
共790条，每页显示
20条
50条
100条
跳转至第
页
确定
